MECP2 and Rett syndrome: Indeed, in order to work, MECP2 gene therapy would have to deliver the precise amount of MECP2 protein in each cell of the body, as too much or too few MECP2 protein can trigger RTT-like symptoms (Clarke and Abdala Sheikh, 2018).